Success Factors in Value Communication Design – Start with the Key Message
July 12, 2012Sales and Marketing interactive apps, value, value communication design
This is Part 1 to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain the …
Success Factors in Value Communication Design – Introduction
July 12, 2012Sales and Marketing interactive apps, sales, value, value communications
This is the introductory article to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain …
Takeda appoints new head of Corporate Communications, Europe and Canada
July 12, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, communications
Takeda Pharmaceuticals has appointed Rob Gallo as head of Corporate Communications, Europe and Canada. Since 2010 Gallo has been the …
NHS appoints first CSS managing directors
July 12, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hakin, NHS
The first round of appointments to commissioning support service (CSS) managing director posts has been made by the NHS Commissioning …
Jobs under threat in Actelion cost saving
July 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts
Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …
Amakem appoints new head of CMC and Operations
July 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing
Belgium-based Amakem NV has announced the appointment of Maarten van Geffen as head of CMC and Operations. The kinase platform …
Fishburn Hedges hired to review Health Foundation’s profile
July 12, 2012Medical Communications Fishburn Hedges, Health Foundation, NHS
PR firm Fishburn Hedges has been appointed by the Health Foundation to review and refresh the charity’s corporate communications. The …
Boehringer collaborates for online ‘beyond pill’ plan
July 11, 2012Medical Communications Boehringer, diabetes, digital, healthrageous
Boehringer Ingelheim is collaborating with US digital health specialist Healthrageous on a scheme to help type II diabetes sufferers manage …
Janssen buys into regenerative diabetes portfolio
July 11, 2012Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes
Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …
Blow for BioInvent as vascular treatment fails
July 11, 2012Research and Development, Sales and Marketing BI-204, BioInvent, LDL, Sweden
Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate. The company’s share …
Significant reorganisation for Chelsea Therapeutics
July 11, 2012Research and Development, Sales and Marketing Chelsea Therapeutics, Northera, biopharma, biotech
Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …
New chief executive for Daiichi Sankyo Europe
July 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo
Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …
R&D, East & West: Lilly invests in its global research network
July 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly
Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …
Negative overtures persuade Sanofi to withdraw drug filing
July 10, 2012Sales and Marketing EMA, Mulsevo, Sanofi, blood clots, withdrawal
Sanofi has withdrawn its marketing applications worldwide for its drug Mulsevo. Designed to stop blood clots in cancer patients receiving …
Priority review for Xarelto’s new indications
July 10, 2012Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Eliquis, FDA, Janssen, Pradaxa, Xarelto
Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …
FDA warns of toxins in glycerin source
July 10, 2012Manufacturing and Production FDA, glycerin, jatropha curcas, toxins
The FDA has asked pharma companies to make sure that glycerin and other ingredients used in their products are not …
Pharma manufacturing news in brief
July 10, 2012Manufacturing and Production Aesica, Affymax, DPT Labs, HAL Allergy BV
Recruitment drive starts at Aesica, Affymax names a new manufacturing head, plus updates from NeoStem, DPT Labs and HAL Allergy.
Siegfried to build new API plant in China
July 10, 2012Manufacturing and Production AMP, API, Hanko, Siegfried
Swiss contract manufacturing organisation Siegfried has announced plans to build a new manufacturing facility in Nantong, near Shanghai in China. …
Savient appoints new president and chief executive
July 10, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ferrari, Savient, cuts
Savient Pharmaceuticals has appointed Louis Ferrari to the role of president and chief executive for the firm. Ferrari succeeds Savient’s …
Shionogi opens UK office
July 9, 2012Research and Development, Sales and Marketing Crestor, Japan, Osaka, Shionogi, cholesterol
Japanese pharma firm Shionogi & Co has opened a new office in London and pledged to expand into Europe. Osaka-based …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
